Data

Identification of Multiple Sclerosis genetic markers leading to clinical benefits to affected patients

BOND University
Tajouri, Lotti ; Staines, Donald ; Marshall-Gradisnik, Sonya ; Brenu, Ekua
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.4225/57/58b60c886ce94&rft.title=Identification of Multiple Sclerosis genetic markers leading to clinical benefits to affected patients&rft.identifier=10.4225/57/58b60c886ce94&rft.publisher=Bond University&rft.description=Multiple Sclerosis (MS) is characterized by severe compromises to neuroimmune processes involving changes in immune cell function, soluble proteins and modulation of inflammatory processes. The introduction of therapeutic agents in the form of immunomodulators; interferon, phosphodiesterase inhibitors and Glatiramer acetate have proven to be useful to some extent in reducing the severity of MS. Herein the implications and effects of these molecules on the immune system in MS are reviewed. Additionally, the available evidence on the mode of action of neuropeptides in MS, their effectiveness on clinical measures, and current knowledge are also reviewed. Data in SPSS software.&rft.creator=Tajouri, Lotti &rft.creator=Staines, Donald &rft.creator=Marshall-Gradisnik, Sonya &rft.creator=Brenu, Ekua &rft.date=2013&rft.type=dataset&rft.language=English Access the data
Cite Saved to MyRDA Save to MyRDA

Access:

Restrictions apply

Full description

Multiple Sclerosis (MS) is characterized by severe compromises to neuroimmune processes involving changes in immune cell function, soluble proteins and modulation of inflammatory processes. The introduction of therapeutic agents in the form of immunomodulators; interferon, phosphodiesterase inhibitors and Glatiramer acetate have proven to be useful to some extent in reducing the severity of MS. Herein the implications and effects of these molecules on the immune system in MS are reviewed. Additionally, the available evidence on the mode of action of neuropeptides in MS, their effectiveness on clinical measures, and current knowledge are also reviewed. Data in SPSS software.

Notes

External Organisations
Griffith University
Associated Persons
Sonya Marshall-Gradisnik (Creator); Ekua Brenu (Creator)Donald Staines (Creator)

Created: 2011 to 2011

Issued: 2013

This dataset is part of a larger collection

Click to explore relationships graph
Help

Related People

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Other Information
Immunomodulators as therapeutic strategies for managing multiple sclerosis

url : http://research.bond.edu.au/en/publications/eb6eb8b7-e898-43a4-aff1-d3f438331e63

Chapter

Identifiers